A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers

Dirk Rades, Daniel Seidl, Stefan Janssen, Samer G. Hakim, Barbara Wollenberg, Tobias Bartscht, Steven E. Schild

Research output: Contribution to journalArticle

Abstract

Background/Aim: Locoregional recurrences of head and neck cancers are often associated with a poor overall survival (OS). Outcomes may be improved with individualized treatments considering a patient’s lifespan. A specific scoring system for estimating OS prognoses is presented. Patients and Methods: In a preceding study of these 60 patients, Eastern Cooperative Oncology Group performance score (ECOG 0-1 versus 2, p=0.002) and N-stage (N0-1 versus N2, p=0.004) were identified as independent predictors of OS. Results: In the current study, the following scoring points were assigned: ECOG performance score 2=0 points, ECOG performance score 0-1=1 point, N2=0 points, N0-1=1 point. Patient scores were 0, 1 or 2 points with 3-year OS rates of 0%, 46% and 83%, respectively (p<0.0001). On multivariable analysis, differences remained significant (p<0.0001). Conclusion: This new scoring system includes three groups of patients with significantly different OS prognoses and can assist physicians when designing individualized therapy for locoregional recurrences of head and neck cancer.

Original languageEnglish (US)
Pages (from-to)1611-1613
Number of pages3
JournalAnticancer Research
Volume38
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Head and Neck Neoplasms
Radiotherapy
Survival
Recurrence
Survival Rate
Physicians
Therapeutics

Keywords

  • Head
  • Locoregional recurrence
  • Neck cancer
  • Overall survival
  • Radiotherapy
  • Scoring system

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Rades, D., Seidl, D., Janssen, S., Hakim, S. G., Wollenberg, B., Bartscht, T., & Schild, S. E. (2018). A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers. Anticancer Research, 38(3), 1611-1613. https://doi.org/10.21873/anticanres.12391

A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers. / Rades, Dirk; Seidl, Daniel; Janssen, Stefan; Hakim, Samer G.; Wollenberg, Barbara; Bartscht, Tobias; Schild, Steven E.

In: Anticancer Research, Vol. 38, No. 3, 01.03.2018, p. 1611-1613.

Research output: Contribution to journalArticle

Rades, D, Seidl, D, Janssen, S, Hakim, SG, Wollenberg, B, Bartscht, T & Schild, SE 2018, 'A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers', Anticancer Research, vol. 38, no. 3, pp. 1611-1613. https://doi.org/10.21873/anticanres.12391
Rades, Dirk ; Seidl, Daniel ; Janssen, Stefan ; Hakim, Samer G. ; Wollenberg, Barbara ; Bartscht, Tobias ; Schild, Steven E. / A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers. In: Anticancer Research. 2018 ; Vol. 38, No. 3. pp. 1611-1613.
@article{7bebe89ded11424ea14d7d83f566da67,
title = "A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers",
abstract = "Background/Aim: Locoregional recurrences of head and neck cancers are often associated with a poor overall survival (OS). Outcomes may be improved with individualized treatments considering a patient’s lifespan. A specific scoring system for estimating OS prognoses is presented. Patients and Methods: In a preceding study of these 60 patients, Eastern Cooperative Oncology Group performance score (ECOG 0-1 versus 2, p=0.002) and N-stage (N0-1 versus N2, p=0.004) were identified as independent predictors of OS. Results: In the current study, the following scoring points were assigned: ECOG performance score 2=0 points, ECOG performance score 0-1=1 point, N2=0 points, N0-1=1 point. Patient scores were 0, 1 or 2 points with 3-year OS rates of 0{\%}, 46{\%} and 83{\%}, respectively (p<0.0001). On multivariable analysis, differences remained significant (p<0.0001). Conclusion: This new scoring system includes three groups of patients with significantly different OS prognoses and can assist physicians when designing individualized therapy for locoregional recurrences of head and neck cancer.",
keywords = "Head, Locoregional recurrence, Neck cancer, Overall survival, Radiotherapy, Scoring system",
author = "Dirk Rades and Daniel Seidl and Stefan Janssen and Hakim, {Samer G.} and Barbara Wollenberg and Tobias Bartscht and Schild, {Steven E.}",
year = "2018",
month = "3",
day = "1",
doi = "10.21873/anticanres.12391",
language = "English (US)",
volume = "38",
pages = "1611--1613",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - A new scoring-system for estimating overall survival after radiotherapy of recurrent head and neck cancers

AU - Rades, Dirk

AU - Seidl, Daniel

AU - Janssen, Stefan

AU - Hakim, Samer G.

AU - Wollenberg, Barbara

AU - Bartscht, Tobias

AU - Schild, Steven E.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background/Aim: Locoregional recurrences of head and neck cancers are often associated with a poor overall survival (OS). Outcomes may be improved with individualized treatments considering a patient’s lifespan. A specific scoring system for estimating OS prognoses is presented. Patients and Methods: In a preceding study of these 60 patients, Eastern Cooperative Oncology Group performance score (ECOG 0-1 versus 2, p=0.002) and N-stage (N0-1 versus N2, p=0.004) were identified as independent predictors of OS. Results: In the current study, the following scoring points were assigned: ECOG performance score 2=0 points, ECOG performance score 0-1=1 point, N2=0 points, N0-1=1 point. Patient scores were 0, 1 or 2 points with 3-year OS rates of 0%, 46% and 83%, respectively (p<0.0001). On multivariable analysis, differences remained significant (p<0.0001). Conclusion: This new scoring system includes three groups of patients with significantly different OS prognoses and can assist physicians when designing individualized therapy for locoregional recurrences of head and neck cancer.

AB - Background/Aim: Locoregional recurrences of head and neck cancers are often associated with a poor overall survival (OS). Outcomes may be improved with individualized treatments considering a patient’s lifespan. A specific scoring system for estimating OS prognoses is presented. Patients and Methods: In a preceding study of these 60 patients, Eastern Cooperative Oncology Group performance score (ECOG 0-1 versus 2, p=0.002) and N-stage (N0-1 versus N2, p=0.004) were identified as independent predictors of OS. Results: In the current study, the following scoring points were assigned: ECOG performance score 2=0 points, ECOG performance score 0-1=1 point, N2=0 points, N0-1=1 point. Patient scores were 0, 1 or 2 points with 3-year OS rates of 0%, 46% and 83%, respectively (p<0.0001). On multivariable analysis, differences remained significant (p<0.0001). Conclusion: This new scoring system includes three groups of patients with significantly different OS prognoses and can assist physicians when designing individualized therapy for locoregional recurrences of head and neck cancer.

KW - Head

KW - Locoregional recurrence

KW - Neck cancer

KW - Overall survival

KW - Radiotherapy

KW - Scoring system

UR - http://www.scopus.com/inward/record.url?scp=85043446033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043446033&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12391

DO - 10.21873/anticanres.12391

M3 - Article

VL - 38

SP - 1611

EP - 1613

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -